Zebra Technologies Corporation (ZBRA)
StalwartFairStock Score: 51/100 — MIXED
Key Financials
| Current Price | $259.35 |
| Market Cap | $10.8B |
| P/E Ratio | 31.28 |
| ROE | 11.78% |
| Dividend Yield | 0% |
| Sector | Technology |
Strengths
- Stable business model in automatic identification with recurring revenue from consumables (labels, wristbands)
- Solid free cash flow generation of $658.5M demonstrates underlying operational cash creation
- Market leadership position in niche industrial equipment sector with switching costs
- 10,700 employees suggest established infrastructure and customer relationships
- Diversified across Connected Frontline and Asset Visibility segments
Concerns
- Extreme valuation disconnect: P/E of 24.89 with EV/EBITDA of 68.74 implies speculative pricing
- Graham Number of $47.74 versus price of $212.47 represents dangerous overvaluation with -345% margin of safety
- Deteriorating financial quality: Piotroski F-Score of only 5/9 and thin 4.75% net margins
- Weak capital efficiency: ROE of 11.68% and ROCE of 6.07% below cost of capital expectations
AI Analysis
Zebra Technologies presents a mixed picture that troubles me as a value investor. The company operates in automatic identification and data capture—a competitively defensible niche with recurring revenue characteristics. Their $1.5B quarterly revenue demonstrates scale, and free cash flow of $658.5M is respectable. However, the valuation screams excess. At $212.47 with a Graham Number of merely $47.74, we face a negative margin of safety of -345%. This isn't a minor overvaluation; it's precipitous. The P/E of 24.89 paired with a Piotroski F-Score of 5/9 signals deteriorating financial quality. Most alarming: an EV/EBITDA of 68.74 is grotesque for industrial equipment—I've rarely seen such multiples justified. The 4.75% net margin in Q4 is thin, and ROE of 11.68% with ROCE of 6.07% tells me capital returns are mediocre. The Altman Z-Score of 2.44 sits in the gray zone, and debt-to-equity of 0.75 adds leverage risk. While the business model has merit for a patient holder at $50, paying $212 requires extraordinary conviction. The high beta of 1.68 amplifies downside risk. I'd rather wait for this stock to normalize toward intrinsic value before deploying capital.
Bull Case
Zebra benefits from secular trends in supply chain automation and IoT adoption. With $658.5M in free cash flow and market-leading position, the company could deploy capital aggressively toward shareholder returns or acquisitions, justifying a premium multiple in a tech-forward environment.
Bear Case
The stock is priced for perfection with valuation multiples suggesting negligible margin of safety. Any revenue deceleration, margin compression, or economic slowdown could trigger significant repricing toward the $47.74 Graham Number, representing 78% downside potential.
Data from SEC filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer